Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic hepatitis B
Research
Tune’s HBV therapy hits the right notes in cells and mice
Tune Therapeutics' epigenetic editor represses HBV genes in cell lines in mice almost completely, setting the stage for clinical trials in humans.
Helen Floersh
Dec 7, 2023 2:05pm
Hepatitis B drug developers chart slow progress, just like hep C
Nov 14, 2023 9:05am
Aligos culls another hep B asset over inconclusive efficacy data
Aug 4, 2023 7:27am
Arbutus' oral checkpoint inhibitor slapped with clinical hold
Apr 25, 2023 11:00am
GSK sees hep B therapy's efficacy drop 60% in phase 2 readout
Nov 8, 2022 11:37am
GSK talks up hep B functional cure after posting phase 2 data
Jun 27, 2022 5:29am